Targeted conformal radiotherapy of disseminated cancers, using the alpha-particle emitting radionuclides astatine-211, bismuth-213 and actinium-225

Projektinformationen

Alpha cancer therapy

ID Finanzhilfevereinbarung: 272348

Projekt abgeschlossen

Startdatum 1 April 2012

Enddatum 1 November 2014

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 259 065,00

EU-Beitrag € 259 065,00

Koordiniert durch

GOETEBORGS UNIVERSITET
Sweden